{"id":539639,"date":"2025-10-31T10:41:13","date_gmt":"2025-10-31T10:41:13","guid":{"rendered":"https:\/\/www.europesays.com\/uk\/539639\/"},"modified":"2025-10-31T10:41:13","modified_gmt":"2025-10-31T10:41:13","slug":"pcca-uk-leadership-announcement","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/uk\/539639\/","title":{"rendered":"PCCA UK Leadership Announcement"},"content":{"rendered":"\n<p class=\"yf-1090901\">Managing Director Sharon Clift has announced her decision to retire within the next year.<\/p>\n<p class=\"yf-1090901\">PCCA UK Managing Director Sharon Clift<\/p>\n<p>    <img fetchpriority=\"high\" decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/ywAAAAAAQABAAACAUwAOw==\" alt=\"PCCA UK Managing Director Sharon Clift as announced her decision to retire within the next year.\" loading=\"eager\" height=\"960\" width=\"960\" class=\"yf-1gfnohs loader\"\/> PCCA UK Managing Director Sharon Clift as announced her decision to retire within the next year.      <\/p>\n<p class=\"yf-1090901\">Precision Health Holdings<\/p>\n<p>    <img decoding=\"async\" src=\"data:image\/gif;base64,R0lGODlhAQABAIAAAAAAAP\/\/\/ywAAAAAAQABAAACAUwAOw==\" alt=\"Precision Health Holdings, the parent company of PCCA UK, is leading the search for the next PCCA UK Managing Director. Inquiries may be directed to info@precision-hh.com.\" loading=\"lazy\" height=\"347\" width=\"960\" class=\"yf-1gfnohs loader\"\/> Precision Health Holdings, the parent company of PCCA UK, is leading the search for the next PCCA UK Managing Director. Inquiries may be directed to info@precision-hh.com.      <\/p>\n<p class=\"yf-1090901\">Northumberland, UK, Oct. 31, 2025 (GLOBE NEWSWIRE) &#8212; PCCA UK\u00a0would like to share an important leadership update. After many years of dedicated service, <b>Managing Director Sharon Clift has announced her decision to retire within the next year<\/b>.<\/p>\n<p class=\"yf-1090901\">Under Sharon\u2019s leadership, PCCA UK has earned the trust of pharmacies, clinicians and industry partners across the United Kingdom and Europe. Her steady guidance has built a strong foundation for the company\u2019s continued success, and she\u00a0will remain actively engaged in leading PCCA UK throughout this transition to ensure continuity and a smooth handover.<\/p>\n<p class=\"yf-1090901\">As PCCA UK prepares for this natural and exciting evolution, our parent company\u2014Precision Health Holdings\u2014is fully committed to our long-term growth. We are part of a broader, integrated network of healthcare innovators within Precision Health, and we\u2019re focused on strengthening our ability to deliver quality, innovation and value to the partners and patients we serve.<\/p>\n<p class=\"yf-1090901\"><b>\u201cSharon\u2019s leadership and commitment have been central to PCCA UK\u2019s success,\u201d\u00a0<\/b>said Jim Smith, Chief Executive Officer of Precision Health Holdings. \u201cAs we look to the future, we see tremendous opportunity. Precision\u00a0Health is here to support PCCA UK through this transition and ensure its next leader has the resources and vision to build on Sharon\u2019s legacy and expand its impact across the region.\u201d<\/p>\n<p class=\"yf-1090901\"><b>\u201cSharon has played an instrumental role in advancing PCCA\u2019s mission and values across the UK and Europe,\u201d <\/b>said Manfredo Thibau, Chief Financial Officer of Precision Health. \u201cHer vision, integrity and deep relationships with our customers and partners have shaped PCCA UK into\u00a0the trusted organization it is today. We are grateful for her leadership and excited to build upon the strong foundation she has created.\u201d<\/p>\n<p class=\"yf-1090901\">The search for PCCA UK\u2019s next Managing Director is now underway. Precision Health is focused on identifying a forward-looking leader who will build upon Sharon\u2019s foundation while guiding the company\u2019s continued growth in the\u00a0years ahead. Inquiries about the Managing Director position may be directed to <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VUexAQZ9VL8kUlfNHQlx8r7S2wim1qi3lSBF2Ar66OoIhQ_76F631isHDMHIGJS2YlQ7ZvRXLWrhJToqO0a_cT1AWfI3CAcJEf2F6pfZ-rY=\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:info@precision-hh.com;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">info@precision-hh.com<\/a>.<\/p>\n<p class=\"yf-1090901\">The entire team at PCCA UK extends our deepest gratitude to Sharon for her leadership and dedication, and to our partners for their continued trust and collaboration as we move confidently into this next phase for PCCA UK.<\/p>\n<p class=\"yf-1090901\">###<\/p>\n<p class=\"yf-1090901\"><b>About PCCA UK<\/b><br \/>PCCA UK Ltd. is a leading provider of pharmaceutical ingredients, formulation support and compounding expertise serving pharmacies, hospitals and healthcare professionals across the United Kingdom and Europe. As part of the Precision\u00a0Health Holdings global network, PCCA UK directly meets the personalised medication needs of patients through its compounding pharmacy, as well as offers specials manufacture, supply and distribution services. With a heritage of innovation and quality\u00a0spanning more than 40 years, PCCA remains committed to advancing the science and practice of personalised medicine through collaboration and service excellence. For more information, visit\u00a0<b><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LW1yXHzQ75RchFym92Mlqv3gGv9DtuIH9gAHqPkPbXSYfQoHQYCIgzomZQ2VYsMo52RLFPhOYfmWDAvSjnciH2Ikvchh8n2spy3_YjY9T659bshZc_GaqPtbetjfZP3cvBuuhL80QIs2hMhruFcBdSY4EO5mzERRVNJhhFG0PD2WxDytYOwR3v9iNBaJlQt8JUFem-ejPwEZIYHtoj_3QaRADJsrSTMJCzH2BdfB7ig6HQ0W3Gn49rHTYlkBxTUtQvTQ8up4Gsr34gBb6T-w7MdIUQgt5sDuLQPSjsgUxfWrO0aMfgnUgLQJ8u1fc5dwDzZT4f_eOQF9Y1xiG7kY-Q==\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:www.pccarx.co.uk;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">www.pccarx.co.uk<\/a>.<\/b><\/p>\n<p class=\"yf-1090901\"><b>About Precision Health Holdings<\/b><br \/>Precision Health Holdings\u00a0is the strategic holding company uniting a family of healthcare innovators to advance the science and practice of personalised medicine. Guided by\u00a0its vision to make personalised medicine a standard of care for patients everywhere, the company provides shared leadership, capital resources and strategic alignment that enables each business to grow, collaborate and deliver meaningful impact. Its mission\u00a0is to improve and extend patients\u2019 lives by bringing innovative approaches to solve health challenges \u2013 building a stronger, more integrated enterprise that drives quality, innovation and value across the healthcare spectrum.<\/p>\n","protected":false},"excerpt":{"rendered":"Managing Director Sharon Clift has announced her decision to retire within the next year. PCCA UK Managing Director&hellip;\n","protected":false},"author":2,"featured_media":539640,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3,4],"tags":[748,393,4884,111095,1144,173985,173987,141720,173986,712,173988,16,15,1764],"class_list":{"0":"post-539639","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-uk","8":"category-united-kingdom","9":"tag-britain","10":"tag-england","11":"tag-great-britain","12":"tag-managing-director","13":"tag-northern-ireland","14":"tag-pcca","15":"tag-pcca-uk","16":"tag-precision-health","17":"tag-precision-health-holdings","18":"tag-scotland","19":"tag-sharon-clift","20":"tag-uk","21":"tag-united-kingdom","22":"tag-wales"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@uk\/115468362380184354","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/539639","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/comments?post=539639"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/posts\/539639\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media\/539640"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/media?parent=539639"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/categories?post=539639"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/uk\/wp-json\/wp\/v2\/tags?post=539639"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}